pindolol has been researched along with Kidney Diseases in 6 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1 Pindolol and propranolol were administered orally in equipotent antihypertensive doses to 14 subjects with mild to moderate hypertension in an open cross-over study." | 9.05 | Effect of pindolol and propranolol on renal function of patients with hypertension. ( Pasternack, A; Pörsti, P; Pöyhönen, L, 1982) |
| "1 Pindolol and propranolol were administered orally in equipotent antihypertensive doses to 14 subjects with mild to moderate hypertension in an open cross-over study." | 5.05 | Effect of pindolol and propranolol on renal function of patients with hypertension. ( Pasternack, A; Pörsti, P; Pöyhönen, L, 1982) |
| " 2 The long-term administration of pindolol (5--20 mg/day) to hypertensive patients with normal renal function was not associated with changes in renal function but in patients with a decreased renal function, pindolol caused an increase in PAH clearance but no change in inulin clearance." | 1.26 | Renal function during acute and long term pindolol treatment in hypertensive patients with normal and decreased glomerular filtration. ( Boner, G; Rosenfeld, J; Wainer, E, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Petrovic, SL | 1 |
| Engel, G | 1 |
| Haugland, RP | 1 |
| Dowben, RM | 1 |
| Rosenfeld, J | 1 |
| Boner, G | 1 |
| Wainer, E | 1 |
| Pasternack, A | 1 |
| Pörsti, P | 1 |
| Pöyhönen, L | 1 |
| Heierli, C | 1 |
| Thoelen, H | 1 |
| Radielovic, P | 1 |
| Ohnhaus, EE | 2 |
| Nüesch, E | 1 |
| Meier, J | 1 |
| Kalberer, F | 1 |
1 trial available for pindolol and Kidney Diseases
| Article | Year |
|---|---|
Effect of pindolol and propranolol on renal function of patients with hypertension.
Topics: Adult; Female; Humans; Hypertension; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Pind | 1982 |
5 other studies available for pindolol and Kidney Diseases
| Article | Year |
|---|---|
Characterization of beta-adrenergic receptor subtypes in androgen-induced mouse kidney hypertrophy using a new high-affinity ligand, [125I]iodocyanopindolol.
Topics: Androgens; Animals; Female; Hypertrophy; Iodocyanopindolol; Kidney Diseases; Ligands; Mice; Pindolol | 1983 |
Renal function during acute and long term pindolol treatment in hypertensive patients with normal and decreased glomerular filtration.
Topics: Administration, Oral; Glomerular Filtration Rate; Humans; Hypertension; Injections, Intravenous; Kid | 1982 |
Renal function following a single dose of pindolol in hypertensive patients with varying degrees of impairment of renal function.
Topics: Adult; Aged; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Diseases; Male | 1977 |
The pharmacokinetics of unchanged pindolol in patients with impaired renal function.
Topics: Creatinine; Fluorometry; Half-Life; Humans; Kidney Diseases; Kidney Function Tests; Kinetics; Pindol | 1973 |
Pharmacokinetics of unlabelled and 14C-labelled pindolol in uraemia.
Topics: Adult; Aged; Carbon Radioisotopes; Female; Fluorometry; Half-Life; Humans; Kidney Diseases; Kinetics | 1974 |